MYCN and survivin cooperatively contribute to malignant transformation of fibroblasts

Nora Hipp, Lisa Christner, Thomas Wirth, Wolfgang Mueller‐Klieser, Stefan Walenta, Evelin Schröck, Klaus‐Michael Debatin, Christian Beltinger

Carcinogenesis · 2013 · 10 citations · 45 references

DOIFull text

Open access

Concepts

Abstract

The oncogenes MYCN and survivin (BIRC5) maintain aggressiveness of diverse cancers including sarcomas. To investigate whether these oncogenes cooperate in initial malignant transformation, we transduced them into Rat-1 fibroblasts. Indeed, survivin enhanced MYCN-driven contact-uninhibited and anchorage-independent growth in vitro. Importantly, upon subcutaneous transplantation into mice, cells overexpressing both instead of either one of the oncogenes generated tumors with shortened latency, marked anaplasia and an increased proliferation-to-apoptosis ratio resulting in accelerated growth. Mechanistically, the increased tumorigenicity was associated with an enhanced Warburg effect and a hypoxia inducible factor 1α linked vascular remodeling. This cooperation between MYCN and survivin may be important in the genesis of several cancers.

References

45